Overview

Effect of PRM-125 on Ambulatory Blood Pressure

Status:
Recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
Evaluation of Once-Daily PRM125 On Ambulatory Blood Pressure in Adults with Hypertension
Phase:
Phase 3
Details
Lead Sponsor:
PRM Pharma, LLC